JPRN-jRCT1020210017Recruiting未知
Relative examination with the allergic disease severity and blood test result
Minakawa Satoko0 sites300 target enrollmentStarted: July 2, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •Blood test result of patient with atopic dermatitis or food allergy of our hospital dermatology from September, 2011 through December, 2025.
Exclusion Criteria
- •Blood test result not to include Thymus and activation-regulated chemokine, IgE, white blood cell, neutrophils, lymphocyte, eosinophils, lactate dehydrogenase, C-reactive protein.
Investigators
Similar Trials
Suspended
Not Applicable
Elucidation of pathophysiology of allergic reaction by COVID-19 vaccineAllergy to COVID19 vaccineJPRN-UMIN000045550ihon University School of Medicine10
Completed
Not Applicable
A Study on the association with allergen, a stimulant and skin condition of babies.Healthy babysJPRN-UMIN000038153Kao Corporation40
Not yet recruiting
Not Applicable
to compare clinical and causative factors of allergic contact dermatitis with the help of indian standard patch test series in a tertiary centreCTRI/2018/07/015053Dr Somya sharma
Recruiting
Unknown
A study of treatment of allergic disorders with MSC-CMAllergic Disorder (such as Pollinosis or Atopic Dermatitis)D006967JPRN-jRCT1051230176agamine Yukiko
Completed
Phase 1
Prevention of Eczema By a Barrier Lipid Equilibrium Strategy (PEBBLES) pilot study - Testing the compliance and saftey of a strategy for improving infant skin function.eczemaSkin - Dermatological conditionsACTRN12609000727246Murdoch Childrens Research Institute10